Literature DB >> 18045542

SnapShot: EGFR signaling pathway.

Yosef Yarden1, Ben-Zion Shilo.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 18045542     DOI： 10.1016/j.cell.2007.11.013

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  64 in total

1.  Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2.

Authors:  Richard A Morgan; James C Yang; Mio Kitano; Mark E Dudley; Carolyn M Laurencot; Steven A Rosenberg
Journal:  Mol Ther       Date:  2010-02-23       Impact factor: 11.454

2.  EGF increases TRPM6 activity and surface expression.

Authors:  Stéphanie Thebault; R Todd Alexander; Wouter M Tiel Groenestege; Joost G Hoenderop; René J Bindels
Journal:  J Am Soc Nephrol       Date:  2008-12-10       Impact factor: 10.121

3.  ZRX1, the first EGFR inhibitor-capecitabine based combi-molecule, requires carboxylesterase-mediated hydrolysis for optimal activity.

Authors:  Maria Ait-Tihyaty; Zakaria Rachid; Anne-Laure Larroque-Lombard; Bertrand J Jean-Claude
Journal:  Invest New Drugs       Date:  2013-12       Impact factor: 3.850

Review 4.  Nuclear mode of the EGFR signaling network: biology, prognostic value, and therapeutic implications.

Authors:  Hui-Wen Lo
Journal:  Discov Med       Date:  2010-07       Impact factor: 2.970

Review 5.  Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations.

Authors:  Woody Han; Hui-Wen Lo
Journal:  Cancer Lett       Date:  2012-01-17       Impact factor: 8.679

6.  In vivo targeting of HER2-positive tumor using 2-helix affibody molecules.

Authors:  Gang Ren; Jack M Webster; Zhe Liu; Rong Zhang; Zheng Miao; Hongguang Liu; Sanjiv S Gambhir; Faisal A Syud; Zhen Cheng
Journal:  Amino Acids       Date:  2011-10-08       Impact factor: 3.520

7.  EGF potentiated oncogenesis requires a tissue transglutaminase-dependent signaling pathway leading to Src activation.

Authors:  Bo Li; Marc A Antonyak; Joseph E Druso; Le Cheng; Alexander Yu Nikitin; Richard A Cerione
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

8.  Targeted therapy in the treatment of malignant gliomas.

Authors:  Rimas V Lukas; Adrienne Boire; M Kelly Nicholas
Journal:  Onco Targets Ther       Date:  2009-02-18       Impact factor: 4.147

9.  HER/ErbB receptor interactions and signaling patterns in human mammary epithelial cells.

Authors:  Yi Zhang; Lee Opresko; Harish Shankaran; William B Chrisler; H Steven Wiley; Haluk Resat
Journal:  BMC Cell Biol       Date:  2009-10-31       Impact factor: 4.241

10.  Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas.

Authors:  M Colomiere; A C Ward; C Riley; M K Trenerry; D Cameron-Smith; J Findlay; L Ackland; N Ahmed
Journal:  Br J Cancer       Date:  2008-12-16       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.